A biotechnology company focused on advanced therapies

Built on a Flexible R&D platform: recombinant viral vector technology with applications in cancer therapy and vaccines

Our technology was developed by world class investigators and leaders in the field

Built for versatility, quickly adaptable to different diseases and targets

EXPERIENCE / TEAM

Scientific team with over two decades of experience in virotherapy with a specific focus in cancer.

PLATFORM / VERSATILITY

Flexible platform of recombinant viral vectors that allows addressing multiple pathologies.

PREPAREDNESS / ADAPTABILITY

Rapidly scalable and adaptable, enabling quick responses to new demands.

Contact

Send us a message
Facebook Twitter Google-plus Youtube Github
A biotechnology company focused on advanced therapies